ID: ALA352048

Max Phase: Preclinical

Molecular Formula: C9H15N3O3

Molecular Weight: 213.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(CO)OCn1ccc(N)nc1=O

Standard InChI:  InChI=1S/C9H15N3O3/c1-2-7(5-13)15-6-12-4-3-8(10)11-9(12)14/h3-4,7,13H,2,5-6H2,1H3,(H2,10,11,14)

Standard InChI Key:  GCIPZASZAKIIIV-UHFFFAOYSA-N

Associated Targets(Human)

ATH-8 cell line 300 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 213.24Molecular Weight (Monoisotopic): 213.1113AlogP: -0.43#Rotatable Bonds: 5
Polar Surface Area: 90.37Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: -0.70CX LogD: -0.70
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.69Np Likeness Score: 0.47

References

1. Abushanab E, Sarma MS..  (1989)  1',2'-seco-dideoxynucleosides as potential anti-HIV agents.,  32  (1): [PMID:2909746] [10.1021/jm00121a016]

Source